Potential for immune-driven viral polymorphisms to compromise antiretroviral-based preexposure prophylaxis for prevention of HIV-1 infection
<h4>Objective</h4> <p>Long-acting rilpivirine is a candidate for pre-exposure prophylaxis (PrEP) for prevention of HIV-1 infection. However, rilpivirine resistance mutations at reverse transcriptase codon 138 (RT-E138X) occur naturally in a minority of HIV-1-infected persons; in p...
Main Authors: | Gatanaga, H, Brumme, Z, Adland, E, Reyes-Terán, G, Avila-Rios, S, Mejía-Villatoro, C, Hayashida, T, Chikata, T, Van Tran, G, Van Nguyen, K, Meza, R, Palou, E, Valenzuela-Ponce, H, Pascale, J, Porras-Cortés, G, Manzanero, M, Lee, G, Martin, J, Carrington, M, John, M, Mallal, S, Poon, A, Goulder, P, Takiguchi, M, Oka, S |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Lippincott, Williams & Wilkins
2017
|
Similar Items
-
AIDS vaccines and preexposure prophylaxis: is synergy possible?
by: Excler, J, et al.
Published: (2011) -
Effective suppression of HIV-1 replication by cytotoxic T lymphocytes specific for pol epitopes in conserved mosaic vaccine immunogens
by: Zou, C, et al.
Published: (2019) -
CD8+ T cells specific for conserved, cross-reactive Gag epitopes with strong ability to suppress HIV-1 replication
by: Murakoshi, H, et al.
Published: (2018) -
Control of HIV-1 by CD8+T cells specific for epitopes of conserved mosaic vaccine immunogens
by: Murakoshi, H, et al.
Published: (2018) -
Stroop interference for different preexposures of the word is affected in inhibition of return
by: Vivas, AB, et al.
Published: (2000)